Chemoinformaics analysis of TRANS-3,4-DIMETHOXYCINNAMYL-ALCOHOL
| Molecular Weight | 194.23 | nRot | 4 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 7 |
| Exact Molecular Weight | 194.094 | nRing | 1 |
| Solubility: LogS | -1.925 | nHRing | 0 |
| Solubility: LogP | 1.565 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 30.1111 |
| nHD | 1 | BPOL | 17.5169 |
| QED | 0.793 |
| Synth | 1.88 |
| Natural Product Likeliness | 0.942 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.024 |
| Pgp-sub | 0.226 |
| HIA | 0.006 |
| CACO-2 | -4.45 |
| MDCK | 0.0000184 |
| BBB | 0.962 |
| PPB | 0.807191 |
| VDSS | 1.292 |
| FU | 0.161263 |
| CYP1A2-inh | 0.864 |
| CYP1A2-sub | 0.887 |
| CYP2c19-inh | 0.078 |
| CYP2c19-sub | 0.868 |
| CYP2c9-inh | 0.019 |
| CYP2c9-sub | 0.719 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.919 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.362 |
| CL | 9.389 |
| T12 | 0.909 |
| hERG | 0.059 |
| Ames | 0.048 |
| ROA | 0.045 |
| SkinSen | 0.954 |
| Carcinogencity | 0.626 |
| EI | 0.966 |
| Respiratory | 0.31 |
| NR-Aromatase | 0.155 |
| Antiviral | No |
| Prediction | 0.709052 |